nnc 112 has been researched along with mdl 100907 in 1 studies
Studies (nnc 112) | Trials (nnc 112) | Recent Studies (post-2010) (nnc 112) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
---|---|---|---|---|---|
32 | 3 | 7 | 1,241 | 65 | 539 |
Protein | Taxonomy | nnc 112 (IC50) | mdl 100907 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullich, S; Catafau, AM; Farre, M; Gunn, RN; Herance, R; Laruelle, M; Rabiner, EA; Radua, J; Searle, GE | 1 |
1 other study(ies) available for nnc 112 and mdl 100907
Article | Year |
---|---|
Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Topics: Adult; Animals; Benzazepines; Benzofurans; Brain; Carbon Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Ketanserin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, Dopamine D1; Serotonin 5-HT2 Receptor Antagonists; Staining and Labeling; Young Adult | 2010 |